Marchex stock faces an AI growth test after Archenia deal

Published on 10/07/2026 at 00:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Marchex stock was last at USD 1.36 on October 6, 2026, after a 6.25 percent session gain. Q3 guidance targets USD 16 million to USD 16.5 million in revenue.

MCHX, US56624R1086, Illustration mit AI erstellt.

Marchex, Inc. (ISIN US56624R1086) was last at USD 1.36 on Nasdaq on October 6, 2026 at 4:00 p.m. ET, up 6.25 percent from USD 1.28. The company is entering its first full quarter with Archenia, an acquisition designed to connect conversation analytics with AI-driven customer acquisition.

Archenia changes the growth equation

According to Yahoo Finance on August 12, 2026, Marchex completed the Archenia acquisition on July 1. Archenia adds lead qualification, conversational artificial intelligence and performance-based customer acquisition capabilities to Marchex's existing analytics platform.

The timing matters because Q2 2026 revenue of USD 11 million reflected Marchex before the Archenia contribution, compared with USD 10.6 million in Q1. Cash stood at USD 8.2 million at June 30, 2026, down from USD 9 million at March 31, according to Yahoo Finance.

Guidance points to a larger quarter

Management expects Q3 2026 revenue of USD 16 million to USD 16.5 million and adjusted EBITDA of USD 2.3 million to USD 2.5 million, with a full quarter of Archenia included. The revenue midpoint of USD 16.25 million is 47.7 percent above Q2 revenue of USD 11 million, making integration and customer conversion the central operating test.

Remio reported on October 4, 2026 that Q2 revenue was USD 11 million, down from USD 11.7 million a year earlier. The same analysis said adjusted EBITDA reached USD 700,000, while adjusted EBITDA excluding USD 1 million in reorganization and acquisition costs was USD 1.7 million.

Valuation remains a sharp contrast

Marchex's market capitalization was USD 60.3 million on October 6, 2026. Its 52-week range was USD 1.15 to USD 2.04, placing the last price USD 0.68 below the yearly high and USD 0.21 above the low. Volume reached 27,942 shares, below the 32,910-share average shown by the finance quote.

Consensus data from Bullstory on October 6, 2026 covered one analyst and carried a consensus rating of none with an average, high and low price target of USD 4.00. That target lies 194.1 percent above the USD 1.36 price, although the target is a forecast rather than a reported operating result.

Stock tests execution after the deal

For investors, the key comparison is the USD 16 million to USD 16.5 million outlook against the USD 11 million Q2 base. Marchex needs Archenia's full-quarter contribution to translate into recurring customer revenue, while adjusted EBITDA must reach the guided USD 2.3 million to USD 2.5 million range.

Marchex's platform now aims to move from identifying customer conversations to qualifying leads, taking automated action and measuring business outcomes. The October 6 price and the wide USD 1.15 to USD 2.04 annual range show that the market is still assigning a substantial execution test to that strategy.